Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10,5 MG fingolimod----[1] 13 💬
2Fingolimod[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 14, 156 💬
3Fingolimod 0.5 MG[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
4Fingolimod 0.5MG[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
5Fingolimod 1.25 MG[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
6Fingolimod hydrochloride[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14 💬
7Fingolimodi----[1] 13 💬
8Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod[1] Glatiramer[1] Glatiramer acetate 💬 [20] MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
9Hidrocloruro DE fingolimod[1] Fingolimod (Fingolimod)[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14 💬
10Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab----[1] 13 💬